| Friday, 9 September 2005: 8:30 AM-5:00 PM | |||
| BAM | |||
Special Sessions (ss) | |||
| AMS in Low Dose Bioscience Workshop | |||
| Organizer: | John Vogel | ||
| 8:30 AM | Frontiers of AMS in bioscience from cells to humans Graham Bench, Bruce A. Buchholz, Darren Hillegonds, M. Mohiuddin Kabir, Ted Ognibene, Magnus Palmblad, John Vogel | ||
| 9:00 AM | Accelerating drug development through the use of AMS - scientific and regulatory perspectives Leslie Chaney, R. Colin Garner | ||
| 9:30 AM | AMS in Drug Development at GSK Graeme C. YOUNG | ||
| 10:00 AM | Morning Coffee at 10:10 to 10:30 | ||
| 10:30 AM | Use of AMS for Investigating the Mechanisms of Tamoxifen Carcinogenesis Karen Brown | ||
| 11:00 AM | Accelerator Mass Spectrometry applications for human nutrition Andrew J. Clifford, Betty J. Burri | ||
| 11:30 AM | 41 For Measuring Dietary Perturbations of Bone Resorption Connie Weaver, Jennifer Cheong, George S. Jackson, David Elmore, George McCabe, Joe R. Nolan, Berdine Martin | ||
| 12:00 PM | Lunch at 12:10 to 1:20 | ||
| 1:00 PM | Ultrasensitive tracking of oxidized guanine incorporation into DNA via nucleotide salvage Sang Soo Hah, Hyung M. Kim, Paul T. Henderson | ||
| 1:20 PM | AMS and isotopic determination of absolute bioavailability for drug approval Darren Groombridge, Graham Lappin, R. Colin Garner | ||
| 1:40 PM | New Tools for Clinical Pharmacology: A microdose study of a new class of anti-HIV compound Stephen R. Dueker, Simon Lee, Le Thuy Vuong, Anders Vahlne | ||
| 2:00 PM | The use of AMS in determining the metabolism and first-pass effects of drugs in humans Daniel Leong, Graham Lappin, R. Colin Garner | ||
| 2:20 PM | BEAMS Lab: A balance between high throughput and high sensitivity Paul L. Skipper, Rosa G. Liberman, Jimmy Flarakos, Steven R. Tannenbaum | ||
| 2:40 PM | Afternoon Coffee at 2:40 to 3:00 | ||
| 3:00 PM | Laser Based 14C Counting, an alternative to AMS in Biological Studies Daniel E. Murnick, Ozgur Dogru, Erhan Ilkmen | ||
| 3:20 PM | Feasibility of long-term human bone health monitoring by 41Ca tracer using Accelerator Mass Spectrometry S. K. Hui, J. Prior, Z. Gelbart, RR Johnson, M. Paul | ||
| 3:40 PM | 41Ca and Accelerator Mass Spectrometry to Monitor Calcium Metabolism in End Stage Renal Disease Patients Robert L. Fitzgerald, Darren J. Hillegonds, Douglas W. Burton, Terrance L. Griffin, Scott Mullaney, John Vogel, Leonard J. Deftos, David A. Herold | ||
| 4:00 PM | 41Ca non-invasively identifies at high sensitivity skeletal perturbations from bisphosphonate therapy and metastatic bone disease Darren J. Hillegonds, Douglas W. Burton, Robert L. Fitzgerald, Eberhard Denk, Meng Yang, Thomas R. Walczyk, Leonard J. Deftos, John S. Vogel | ||
| 4:20 PM | A new concept for a biomedical AMS system Hans-Arno Synal, Martin Suter | ||
See more of The 10th International Conference on Accelerator Mass Spectrometry (September 5-10, 2005)